Common drug tested as lifesaver for dangerous transplant side effect
NCT ID NCT07279610
Summary
This study is testing whether N-acetylcysteine (NAC), a safe and affordable drug, can treat a severe and potentially fatal blood vessel complication that can happen after a stem cell transplant. It will enroll 44 adult patients who have developed this condition, called TA-TMA, to see if NAC can improve their blood counts, organ function, and survival. The goal is to find a more accessible and effective treatment than current expensive options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THROMBOTIC MICROANGIOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, China
Conditions
Explore the condition pages connected to this study.